Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trial
Publication

Publications

Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trial

Title
Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trial
Type
Another Publication in an International Scientific Journal
Year
2022
Authors
Butler, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Siddiqi, TJ
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Filippatos, G
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ferreira, JP
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Pocock, SJ
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Zannad, F
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Anker, SD
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 24
Pages: 245-248
ISSN: 1388-9842
Publisher: Wiley-Blackwell
Indexing
Other information
Authenticus ID: P-00W-0BA
Resumo (PT):
Abstract (EN):
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 4
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Validation of a risk score to estimate cardiac risk in subjects from the general population on cardioactive treatment (2008)
Another Publication in an International Scientific Journal
Pimenta J; Bettencourt P; Azevedo A
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry (2020)
Another Publication in an International Scientific Journal
Garrido¿Lestache, EB; Pinilla, JG; Villa, BG; Sahuquillo, A; Marques, RB; Calvo, FT; Perez¿Martinez, M; Gracia¿Rodenas, M; Garrido¿Bravo, IP; Pastor¿Perez, F; Pascual¿Figal, D; Molina, BD; Orus, J; Gonzalo, FE; Bertomeu, V; Valero, R; Martinez¿Abellan, R; Quiles, J; Rodrigez¿Ortega, J; Mateo, I...(mais 669 authors)
Targeting myocardial remodelling to develop novel therapies for heart failure A position paper from the Working Group on Myocardial Function of the European Society of Cardiology (2014)
Another Publication in an International Scientific Journal
Tarone, G; Balligand, JL; Bauersachs, J; Clerk, A; De Windt, L; Heymans, S; Hilfiker Kleiner, D; Hirsch, E; Iaccarino, G; Knoell, R; Leite-Moreira AF; Andre P Lourenco; Mayr, M; Thum, T; Tocchetti, CG
Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach? (2017)
Another Publication in an International Scientific Journal
Ferreira, JP; Mentz, RJ; Pizard, A; Pitt, B; Zannad, F

See all (88)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-31 at 04:58:29 | Privacy Policy | Personal Data Protection Policy | Whistleblowing